Robin Kraak

Showing 1-8 of 8 articles

Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial

Kraak R, Tijssen R, van Dongen I, Elias J, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Tijssen J, Piek J, de Winter R, Henriques J, Wykrzykowska J

December 4, 2020 | 10.4244/EIJ-D-18-00884

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Kerkmeijer L, Tijssen RY, Hofma S, van der Schaaf R, Arkenbout K, Kraak R, Weevers A, Piek J, de Winter R, Tijssen J, Henriques J, Wykrzykowska J, Ijsselmuiden A, Kauer F, Beijk M, Vis M, Koch K

September 20, 2019 | 10.4244/EIJ-D-19-00325

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

Tijssen RY, Kraak R, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Elias J, van Dongen I, Koch K, Baan Jr J, Vis M, de Winter R, Piek J, Tijssen J, Henriques J, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-18-00335

Coronary interventions

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial

Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R, Tijssen J, Onuma Y, Serruys P, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-17-01152

Coronary interventions

Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria

Kraak R, Grundeken M.J, Hassell M, Elias J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Thijssen J, de Winter R, Wykrzykowska J

August 5, 2016 | 10.4244/EIJV12I5A95

Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography

Grundeken M.J, Hassell M, Kraak R, de Bruin D, Koch K, Henriques J, van Leeuwen T, Thijssen J, Piek J, de Winter R, Wykrzykowska J

December 20, 2015 | 10.4244/EIJY14M08_15

Coronary interventions

The future of BRS in bifurcations

Kraak R, Grundeken M.J, Onuma Y, Tu S, Wykrzykowska J, Chevalier B, Ormiston J, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA45

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

Kraak R, Hassell M, Grundeken M.J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Arkenbout E, Thijssen J, de Winter R, Wykrzykowska J

February 20, 2015 | 10.4244/EIJY14M08_08

Latest news

EDITORIAL

A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…

June 11, 2021

NEW

Intracoronary OCT: State of the Art and Future Directions

Ziad A. Ali et al.

June 11, 2021

PCR Companion attending EuroPCR? Activate your free subscription!

May 28, 2021

TRIALS BOOK

Access the full Trials Book 2021

(Thanks to the support of Biotronik)

May 18, 2021

JAA

This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...

June 8, 2021

NEW

Joint EAPCI/ACVC expert consensus on pVADs

Alaide Chieffo et al.

May 31, 2021

JAA

New JAA's: Impact of HPR on clopidogrel monotherapy and more...